Pityriasis rosea
Definition
Pityriasis rosea is a common type of skin rash most often seen in young adults.
Causes
Pityriasis rosea is believed to be caused by a virus. It occurs most often in the fall and spring.
Although pityriasis rosea may occur in more than one person in a household at a time, it is not thought to spread from one person to another. Females seem to be more affected than males.
Symptoms
Attacks most often last 4 to 8 weeks. Symptoms may disappear by 3 weeks or last as long as 12 weeks.
The rash starts with a single large called a herald patch. After several days, more skin rashes will appear on the chest, back, arms, and legs.
The skin rashes:
Other symptoms may include:
Exams and Tests
Your health care provider can often diagnose pityriasis rosea by the way the rash looks.
In rare cases, the following tests are needed:
Treatment
If symptoms are mild, you may not need treatment.
Your provider may suggest gentle bathing, mild lubricants or cream, or mild hydrocortisone creams to soothe your skin.
Antihistamines taken by mouth may be used to reduce itching. You can buy antihistamines at the store without a prescription.
Moderate sun exposure or ultraviolet (UV) light treatment may help make the rash go away more quickly. However, you must be careful to avoid sunburn.
Outlook (Prognosis)
Pityriasis rosea often goes away within 4 to 8 weeks. It usually doesn't come back.
When to Contact a Medical Professional
Contact your provider for an appointment if you have symptoms of pityriasis rosea.
References
Dinulos JGH. Psoriasis and other papulosquamous diseases. In: Dinulos JGH, ed. Habif's Clinical Dermatology: A Color Guide in Diagnosis and Therapy. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 8.
James WD, Elston DM, Treat JR, Rosenbach MA, Neuhaus IM. Pityriasis rosea, pityriasis rubra pilaris, and other papulosquamous and hyperkeratotic diseases. In: James WD, Elston DM, Treat JR, Rosenbach, MA, Neuhaus IM, eds. Andrews' Diseases of the Skin: Clinical Dermatology. 13th ed. Philadelphia, PA: Elsevier; 2020:chap 11.
Review Date: 10/20/2022
Reviewed By: Linda J. Vorvick, MD, Clinical Professor, Department of Family Medicine, UW Medicine, School of Medicine, University of Washington, Seattle, WA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
- © 1997-2024 All rights reserved.